en · de · es · fr · pt
glossary-desk.peptides9002.com › Topic › Storage, Analysis, And Regulatory Status — Reference Sheet

Storage, Analysis, And Regulatory Status — Reference Sheet

By Editorial Desk · published 2025-11-28 · last reviewed 2026-01-03 · Topic

intranasal delivery raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-01-03. Anything still debated is marked as such rather than presented as settled.

Storage, Analysis, and Regulatory Status

Dry powder is normally held at -20 degrees Celsius or lower, in a sealed container with desiccant and protection from light. Reconstituted solutions are usually kept at 2 to 8 degrees Celsius for short periods and frozen for longer ones. Proline residues at several positions are generally associated with some resistance to peptidase attack, but chemical stability still declines at neutral to alkaline pH and at elevated temperature. Exact shelf-life figures are product-specific and are not standardised across suppliers.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.

Stability, Handling, and Analytical Control

Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres is the standard purity method. Mass spectrometry, typically electrospray ionisation, confirms identity through the expected mass-to-charge pattern. Amino acid analysis can verify composition independently. Chiral purity requires separate techniques such as derivatisation followed by chromatographic separation, and such data are rarely reported for research-grade material.

Quantification in biological matrices relies on liquid chromatography coupled to tandem mass spectrometry with stable-isotope internal standards. Low plasma concentrations and adsorption to container surfaces both complicate measurement. Solid-phase extraction is often needed to reduce matrix interference before injection. Reported limits of quantification differ widely between laboratories, which makes direct comparison of pharmacokinetic results difficult and limits meta-analysis.

Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.

Selank at a glance

PropertyValueNotes
AppearanceWhite to off-white powderLyophilised solid form
Solubility classFreely soluble in waterHydrophilic heptapeptide
Dry storage temperature-20 degrees Celsius or lowerSealed, desiccated, protected from light
Solution storage2 to 8 degrees Celsius short termAvoid repeated freeze-thaw cycles
Common identification methodReversed-phase HPLC with mass spectrometryConfirms purity and molecular mass

Background and Peptide Identity

Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.

Reported activity for Selank centers on anxiolytic and nootropic effects. Russian clinical reports describe use in anxiety and in cognitive or attention-related complaints. Most of this evidence comes from studies conducted by the same research groups that developed the peptide. Independent replication in other countries remains limited, and no major Western regulatory agency has approved the compound for any indication. The gap between local reports and external verification is a recurring point in discussions of the peptide.

Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.

Related pages on this site

Identity and Structural Background

Development work on the compound began in the 1980s and 1990s at the Institute of Molecular Genetics in Moscow, within the same research programme that produced the peptide Semax. Early investigators sought a tuftsin derivative with improved resistance to enzymatic breakdown and with activity in the central nervous system after peripheral administration. Most of the primary literature from this period was published in Russian, a factor that still shapes how easily the findings can be checked by outside groups.

Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.

Notes from published material

==== Russia ==== According to the Foreign Policy Research Institute, Russia has 112 think tanks, while Russian think tanks claimed four of the top ten spots in 2011's "Top Thirty Think Tanks in Central and Eastern Europe". Notable Russian think tanks include:

Some of these differences include the "vigor" or speed of fermentation, temperature tolerance, the production of volatile sulfur compounds (such as hydrogen sulfide) and other compounds that may influence the aroma of the wine. In modern winemaking, winemakers have the option to select from a diverse range of yeast strains, each offering distinct characteristics that influence the wine's sensory profile. These strains are readily available for purchase from specialized suppliers. Winemakers can now easily access yeast strains that accentuate desirable features in wine, such as aromatic compounds, mouthfeel, and fermentation kinetics. This commercial availability of yeast strains has revolutionized the art of winemaking by allowing for more precise control over the fermentation process and the resultant wine's character.

The plebiscites asked voters whether they wanted their homeland to remain in East Prussia or to become a part of it, as to the Marienwerder Plebiscite Area, which was part of Weimar Germany, or to become part of Poland (the alternatives for the voters were not Poland or Germany but Poland or East Prussia, the latter of which was not a sovereign nation). All inhabitants of the plebiscite areas older than 20 or those who were born in the area before 1 January 1905 were entitled to return to vote.

Sources: en.wikipedia.org

Background from the literature

In contrast, Slavic settlements in southern Ukraine started to appear relatively early during Cuman rule, with the earliest, such as Oleshia, dating back to the 11th century. Early "Proto-Cossack" groups are generally reported to have come into existence within what is now Ukraine prior to the 13th century as the influence of Cumans grew weaker, although some have ascribed their origins to as early as the mid-8th century. Some historians suggest that the Cossack people were descended from East Slavs, Turks, Tatars, Circassians and others who settled or passed through the vast regions. There are archeological indications, according to Turkologists, that Cossacks are descendants of the native Cumans of Ukraine, who had lived there long before the Mongol invasion. Other theories expand upon that assertion to suggest that the first Cossacks were of Turkic origin. For example, according to Serhii Plokhy, the first Cossacks were of Turkic rather than Slavic stock. Christoph Baumer states that Cossack predecessors from the thirteenth century onward were mainly of Turkic stock, but from the sixteenth century the Cossacks were increasingly joined by Slavs such as Russians and Poles, Baltic Lithuanians and people from today's Ukraine, thus becoming a Slav-Tatar ethnic hybrid. The theory is also reflected in the Constitution of Pylyp Orlyk of 1710 and the Hrabianka Chronicle, which claims Khazar origins for the Cossacks. The Khazar origin myth became popular during the rule of Ivan Mazepa, a reaction against the Polish myth of Sarmatism.

Other notable variants include 6 other WHO-designated variants under investigation and Cluster 5, which emerged among mink in Denmark and resulted in a mink euthanasia campaign rendering it virtually extinct.

Dissociation of the target mRNA strand from RISC after the cleavage allows more mRNA to be silenced; this dissociation process is likely to be promoted by extrinsic factors driven by ATP hydrolysis. Sometimes, cleavage of the target mRNA molecule does not occur. In some cases, the endonucleolytic cleavage of the phosphodiester backbone may be suppressed by mismatches of siRNA and target mRNA near the cleaving site. Other times, the Argonaute proteins of the RISC lack endonuclease activity even when the target mRNA and siRNA are perfectly paired. In such cases, gene expression will be silenced by an miRNA-induced mechanism instead.

Sources: en.wikipedia.org

Frequently asked questions

How should the powder be stored?

Dry powder is normally held at -20 degrees Celsius or below in a sealed, light-protected container with desiccant. Brief room-temperature handling during weighing is generally tolerated. Storage instructions vary between suppliers, so the accompanying certificate of analysis should be followed.

How is identity confirmed?

Reversed-phase HPLC establishes purity, while mass spectrometry confirms the expected molecular mass. Sequence confirmation may use tandem mass spectrometry or peptide mapping. A certificate of analysis typically reports these results alongside the analytical method applied.

Is it legal to purchase?

In Russia it is a registered medicine available by prescription. In many other countries it is not approved for human use and is supplied only as a research chemical. Import and possession rules differ by jurisdiction, and buyers are responsible for checking local requirements.

How should the powder be stored?

Dry powder is best kept sealed, protected from light, and held at minus 20 degrees Celsius or below. Desiccant packaging helps limit moisture uptake because the material is hygroscopic. A sealed vial should be allowed to equilibrate to room temperature before opening to reduce condensation.

Network